Open Partial Horizontal Laryngectomy in the Elderly: Oncological and Functional Outcomes
The Laryngoscope · 2025-06 · 135 (6) · 2030-2036
DOI: 10.1002/lary.31981 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 15.01.2025. Verfasst von Andy Bertolin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology Unit, Vittorio Veneto Hospital (Treviso), Vittorio Veneto, Italy. Hauptthemen laut MEDLINE: Laryngectomy, Laryngeal Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objectives
The aim of the present study was to investigate the oncological and functional prognostic implication of perioperative risk factors in the elderly patient who underwent open partial horizontal laryngectomy (OPHL). Study Design A single institution, retrospective case–cohort study.
Methods
The present study retrospectively reviewed the clinical charts of a cohort of 100 elderly laryngeal squamous cell carcinoma (LSCC) patients who underwent OPHL at our institution. Oncological and functional results were evaluated through univariate analysis.
Results
The overall recurrence rate was 19%. The 2 years overall and disease‐specific survivals were 72% and 90%, respectively. No perioperative deaths were reported. A postoperative complication was reported in 20 cases (20%). Fifty‐four patients (54%) were decannulated during the hospitalization. A percutaneous endoscopic gastrostomy procedure was performed in 12 patients (12%) due to persistent dysphagia. Twenty‐six patients experienced postoperative late sequelae (26%), in terms of postoperative laryngeal obstruction (POLO) in 17 cases. A total of 80 patients (80%) were finally successfully decannulated. A functional total laryngectomy was performed in 6 cases.
Conclusions
The indication to OPHL should be carefully evaluated in the elderly. In appropriately selected patient, OPHL represents a safe and effective therapeutic option. Cervical positive nodes and an incomplete resection of the tumor with positive surgical margins remain in such population the main prognostic factors for the oncological outcome, these factors have a negative impact on the functional outcome too, due to the need for adjuvant treatment. Hence, OPHL should be offered as a single‐modality treatment especially in the elderly. Level of Evidence 4 Laryngoscope , 135:2030–2036, 2025
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Otolaryngology Unit, Vittorio Veneto Hospital (Treviso), Vittorio Veneto, Italy.
- ENT Department, San Giovanni Bosco Hospital, Torino, Italy.
- Oncology Department, Torino University, Torino, Italy.
- Department of Neuroscience, Audiology Section, Padova University, Treviso, Italy.
- Department of Statistical Sciences, Padova University, Padova, Italy.
- Department of Neuroscience, Otolaryngology Section, Padova University, Padova, Italy.
ORCID-Profile: Leonardo Franz, Marco Lionello
Zitieren
APA
Bertolin, A., Succo, G., Crosetti, E., Varago, C., Laura, E., Franz, L., Nguyen, T. K. H., Di Chicco, A., Battistuzzi, V., Grassetto, A., & Lionello, M. (2025). Open Partial Horizontal Laryngectomy in the Elderly: Oncological and Functional Outcomes. The Laryngoscope, 135(6), 2030-2036. https://doi.org/10.1002/lary.31981
Vancouver
Bertolin A, Succo G, Crosetti E, Varago C, Laura E, Franz L, et al. Open Partial Horizontal Laryngectomy in the Elderly: Oncological and Functional Outcomes. The Laryngoscope. 2025;135(6):2030-2036. doi:10.1002/lary.31981
BibTeX
@article{Bertolin2025,
author = {Bertolin, Andy and Succo, Giovanni and Crosetti, Erika and Varago, Chiara and Laura, Elisa and Franz, Leonardo and Nguyen, Thi K H and Di Chicco, Alessandra and Battistuzzi, Veronica and Grassetto, Alberto and Lionello, Marco},
title = {Open Partial Horizontal Laryngectomy in the Elderly: Oncological and Functional Outcomes},
journal = {The Laryngoscope},
year = {2025},
volume = {135},
number = {6},
pages = {2030--2036},
doi = {10.1002/lary.31981}
}
EUVIMED